These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 6305440
41. Determination of delta 9-tetrahydrocannabinol-11-oic acid in urine as its pentafluoropropyl-pentafluoropropionyl derivative by GC/MS utilizing negative ion chemical ionization. Karlsson L, Jonsson J, Aberg K, Roos C. J Anal Toxicol; 1983; 7(4):198-202. PubMed ID: 6314044 [Abstract] [Full Text] [Related]
42. In vivo metabolism of the n-propyl homologues of delta-8- and delta-9-tetrahydrocannabinol in the mouse. Brown NK, Harvey DJ. Biomed Environ Mass Spectrom; 1988 Apr 01; 15(7):403-10. PubMed ID: 2839261 [Abstract] [Full Text] [Related]
43. Hair analysis for illicit drugs by using capillary zone electrophoresis-electrospray ionization-ion trap mass spectrometry. Gottardo R, Bortolotti F, De Paoli G, Pascali JP, Miksík I, Tagliaro F. J Chromatogr A; 2007 Aug 03; 1159(1-2):185-9. PubMed ID: 17240388 [Abstract] [Full Text] [Related]
44. Quantitative determination of delta 9-tetrahydrocannabinol in cadaver blood. Rosenthal D, Brine D. J Forensic Sci; 1979 Apr 03; 24(2):282-90. PubMed ID: 232121 [Abstract] [Full Text] [Related]
45. Characterization of three monohydroxyacid and two dihydroxyacid metabolites of delta 1-tetrahydrocannabinol in mouse liver. Harvey DJ, Paton WD. Res Commun Chem Pathol Pharmacol; 1976 Apr 03; 13(4):585-99. PubMed ID: 1265340 [Abstract] [Full Text] [Related]
46. Oral fluid testing for cannabis: on-site OraLine IV s.a.t. device versus GC/MS. Cirimele V, Villain M, Mura P, Bernard M, Kintz P. Forensic Sci Int; 2006 Sep 12; 161(2-3):180-4. PubMed ID: 16854544 [Abstract] [Full Text] [Related]
47. Determination of pravastatin sodium and its major metabolites in human serum/plasma by capillary gas chromatography/negative ion chemical ionization mass spectrometry. Funke PT, Ivashkiv E, Arnold ME, Cohen AI. Biomed Environ Mass Spectrom; 1989 Oct 12; 18(10):904-9. PubMed ID: 2508807 [Abstract] [Full Text] [Related]
48. [Fuorometric analysis of delta-9-tetrahydrocannabinol and its metabolites in urine]. Bourdon R. Eur J Toxicol Environ Hyg; 1976 Oct 12; 9(1):11-21. PubMed ID: 1253830 [Abstract] [Full Text] [Related]
49. Enantiospecific quantification of hexobarbital and its metabolites in biological fluids by gas chromatography/electron capture negative ion chemical ionization mass spectrometry. Prakash C, Adedoyin A, Wilkinson GR, Blair IA. Biol Mass Spectrom; 1991 Sep 12; 20(9):559-64. PubMed ID: 1782205 [Abstract] [Full Text] [Related]
50. Metabolism of (+)-trans-delta 8-tetrahydrocannabinol in the mouse in vitro and in vivo. Harvey DJ, Marriage HJ. Drug Metab Dispos; 1987 Sep 12; 15(6):914-20. PubMed ID: 2893721 [Abstract] [Full Text] [Related]
51. Cannabinoids in humans. I. Analysis of delta 9-tetrahydrocannabinol and six metabolites in plasma and urine using GC-MS. Kemp PM, Abukhalaf IK, Manno JE, Manno BR, Alford DD, Abusada GA. J Anal Toxicol; 1995 Sep 12; 19(5):285-91. PubMed ID: 7500614 [Abstract] [Full Text] [Related]
52. Radioimmunoassays for cannabinoids. Cook CE, Seltzman HH, Schindler VH, Tallent CR, Chin KM, Pitt CG. NIDA Res Monogr; 1982 Sep 12; 42():19-32. PubMed ID: 6294523 [Abstract] [Full Text] [Related]
53. Pharmacokinetics of nabilone, a psychotropically active 9-ketocannabinoid, in the dog. Utilization of quantitative selected ion monitoring and deuterium labeling. Sullivan HR, Kau DL, Wood PG. Biomed Mass Spectrom; 1978 Apr 12; 5(4):296-301. PubMed ID: 638236 [Abstract] [Full Text] [Related]
54. A chemical ionization selected ion monitoring assay for methylphenidate and ritalinic acid. Iden CR, Hungund BL. Biomed Mass Spectrom; 1979 Oct 12; 6(10):422-6. PubMed ID: 526558 [Abstract] [Full Text] [Related]
55. Determination of peptidoaminobenzophenone (2-o-chlorobenzoyl-4-chloro-N-methyl-N'-glycylglycinanilide) and its metabolites in human plasma by glass capillary gas chromatography negative ion chemical ionization mass spectrometry--1. Hashimoto S, Sakurai E, Mizobuchi M, Takahashi S, Yamamoto K, Momose T. Biomed Mass Spectrom; 1982 Dec 12; 9(12):546-51. PubMed ID: 6131705 [Abstract] [Full Text] [Related]
56. Pharmacokinetics of delta 9-tetrahydrocannabinol in rabbits following single or multiple intravenous doses. Leuschner JT, Harvey DJ, Bullingham RE, Paton WD. Drug Metab Dispos; 1986 Dec 12; 14(2):230-8. PubMed ID: 2870899 [Abstract] [Full Text] [Related]
57. Ultrasensitive measurement of delta-9-tetrahydrocannabinol with a high energy dynode detector and electron-capture negative chemical-ionization mass spectrometry. Shaw LM, Edling-Owens J, Mattes R. Clin Chem; 1991 Dec 12; 37(12):2062-8. PubMed ID: 1662560 [Abstract] [Full Text] [Related]
58. Detection and quantitation of urinary 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid, a metabolite of tetrahydrocannabinol, by capillary gas chromatography and electron impact mass fragmentography. Paul BD, Mell LD, Mitchell JM, McKinley RM, Irving J. J Anal Toxicol; 1987 Dec 12; 11(1):1-5. PubMed ID: 3029505 [Abstract] [Full Text] [Related]
59. Detection and quantitation of cannabinoids in biological fluids: specificity and kinetics after smoking. Scherrmann JM, Hoellinger H, Nguyen-Hoang-Nam, Boudet L, Pichon J, Do-Cao-Thang. Clin Toxicol; 1981 May 12; 18(5):565-71. PubMed ID: 6268351 [Abstract] [Full Text] [Related]
60. Single dose kinetics of deuterium labelled delta 1-tetrahydrocannabinol in heavy and light cannabis users. Ohlsson A, Lindgren JE, Wahlén A, Agurell S, Hollister LE, Gillespie HK. Biomed Mass Spectrom; 1982 Jan 12; 9(1):6-10. PubMed ID: 6277407 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]